Vault-13

DIADEMA PARTNERS LP

MORRISTOWN, NJ · CIK 2026172 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2024 · limited partnership

As an employer

US visa salary filings

Job titleFilingsMedianRange
Trader/AnalystMorristown, NJ 1 $180,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Diadema Partners LP.

$283.2m reported value +16.9% vs Q1 2026
78positions
62.5%in top 10
30 new 21 added 19 reduced 38 sold out vs Q1 2026

Options: 47 call positions ($329.0m notional), 24 put positions ($179.1m notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 52,989 $28.7m10.14% 10.14% AddedShares held: Q3 2025 0, Q4 2025 10.0k, Q1 2026 27.3k, Q2 2026 53.0k +25.7k +25,686 94.1%
2 REVOLUTION MEDICINES INC COM RVMD RVMD 139,218 $26.1m9.21% 9.21% AddedShares held: Q3 2025 59.1k, Q4 2025 37.0k, Q1 2026 80.9k, Q2 2026 139.2k +58.3k +58,346 72.2%
3 ABIVAX SA SPONSORED ADS ABVX ABVX 163,644 $21.6m7.63% 7.63% AddedShares held: Q3 2025 41.6k, Q4 2025 75.6k, Q1 2026 75.9k, Q2 2026 163.6k +87.7k +87,700 115.5%
4 COGENT BIOSCIENCES INC COM COGT COGT 493,664 $19.1m6.75% 6.75% AddedShares held: Q3 2025 97.8k, Q4 2025 131.9k, Q1 2026 322.8k, Q2 2026 493.7k +170.9k +170,900 53.0%
5 BRIDGEBIO PHARMA INC NOTE 1.750% 3/0 · principal BBIO 1.75 03.01.31 · principal BBIO 1.75 03.01.31 250,000 $18.6m6.58% 6.58% NewPrincipal held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 250.0k
6 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 312,846 $17.9m6.32% 6.32% AddedShares held: Q3 2025 212.9k, Q4 2025 146.4k, Q1 2026 148.2k, Q2 2026 312.8k +164.6k +164,617 111.1%
7 VIKING THERAPEUTICS INC COM VKTX VKTX 441,808 $17.2m6.09% 6.09% ReducedShares held: Q3 2025 193.7k, Q4 2025 336.8k, Q1 2026 525.2k, Q2 2026 441.8k -83.4k -83,373 -15.9%
8 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 272,214 $11.1m3.91% 3.91% NewShares held: Q3 2025 0, Q4 2025 30.0k, Q1 2026 0, Q2 2026 272.2k
9 KODIAK SCIENCES INC COM KOD KOD 218,117 $8.5m3.00% 3.00% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 193.0k, Q2 2026 218.1k +25.2k +25,155 13.0%
10 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 254,863 $8.1m2.86% 2.86% AddedShares held: Q3 2025 124.4k, Q4 2025 70.3k, Q1 2026 193.2k, Q2 2026 254.9k +61.7k +61,674 31.9%
11 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 571,107 $7.6m2.68% 2.68% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 571.1k
12 ARCUS BIOSCIENCES INC COM RCUS RCUS 223,810 $6.9m2.44% 2.44% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 238.1k, Q2 2026 223.8k -14.3k -14,332 -6.0%
13 JOHNSON & JOHNSON COM JNJ JNJ 22,000 $5.6m1.97% 1.97% ReducedShares held: Q3 2025 0, Q4 2025 66.4k, Q1 2026 53.8k, Q2 2026 22.0k -31.8k -31,771 -59.1%
14 NOVO-NORDISK A S ADR NVO NVO 100,000 $4.8m1.70% 1.70% AddedShares held: Q3 2025 25.0k, Q4 2025 0, Q1 2026 14.6k, Q2 2026 100.0k +85.4k +85,423 586.0%
15 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 294,811 $4.4m1.56% 1.56% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 244.8k, Q2 2026 294.8k +50.0k +50,000 20.4%
16 RELAY THERAPEUTICS INC COM RLAY RLAY 230,677 $4.3m1.52% 1.52% NewShares held: Q3 2025 43.6k, Q4 2025 0, Q1 2026 0, Q2 2026 230.7k
17 ZYMEWORKS INC COM ZYME ZYME 142,132 $3.7m1.31% 1.31% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 142.1k, Q2 2026 142.1k
18 BIOAGE LABS INC COM BIOA BIOA 146,334 $3.6m1.27% 1.27% AddedShares held: Q3 2025 0, Q4 2025 271.2k, Q1 2026 60.0k, Q2 2026 146.3k +86.3k +86,334 143.9%
19 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 522,619 $3.6m1.26% 1.26% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 522.6k
20 NURIX THERAPEUTICS INC COM NRIX NRIX 121,539 $2.9m1.04% 1.04% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 121.5k
21 CORBUS PHARMACEUTICALS HLDGS COM NEW CRBP CRBP 301,264 $2.8m1.00% 1.00% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 440.0k, Q2 2026 301.3k -138.7k -138,693 -31.5%
22 INDIVIOR PHARMACEUTICALS INC COM INDV INDV 67,512 $2.8m0.98% 0.98% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 71.4k, Q2 2026 67.5k -3.9k -3,864 -5.4%
23 INVENTIVA SA ADS IVA IVA 740,786 $2.7m0.96% 0.96% AddedShares held: Q3 2025 0, Q4 2025 334.3k, Q1 2026 352.4k, Q2 2026 740.8k +388.4k +388,387 110.2%
24 ORUKA THERAPEUTICS INC COM ORKA ORKA 27,799 $2.6m0.93% 0.93% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 27.8k
25 VAXCYTE INC COM PCVX PCVX 45,071 $2.6m0.93% 0.93% AddedShares held: Q3 2025 218.3k, Q4 2025 23.0k, Q1 2026 25.1k, Q2 2026 45.1k +20.0k +20,000 79.8%
26 RELMADA THERAPEUTICS INC COM RLMD RLMD 361,367 $2.5m0.88% 0.88% AddedShares held: Q3 2025 0, Q4 2025 389.4k, Q1 2026 200.8k, Q2 2026 361.4k +160.5k +160,525 79.9%
27 VERA THERAPEUTICS INC CL A VERA VERA 57,608 $2.5m0.87% 0.87% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 57.6k
28 CONTINEUM THERAPEUTICS INC CL A CTNM CTNM 119,733 $2.0m0.69% 0.69% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 119.7k
29 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 462,724 $2.0m0.69% 0.69% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 476.4k, Q2 2026 462.7k -13.7k -13,700 -2.9%
30 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 78,391 $1.9m0.67% 0.67% ReducedShares held: Q3 2025 0, Q4 2025 62.3k, Q1 2026 187.3k, Q2 2026 78.4k -108.9k -108,916 -58.1%
31 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 100,000 $1.8m0.65% 0.65% NewShares held: Q3 2025 0, Q4 2025 21.1k, Q1 2026 0, Q2 2026 100.0k
32 MACROGENICS INC COM MGNX MGNX 374,403 $1.7m0.61% 0.61% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 600.0k, Q2 2026 374.4k -225.6k -225,597 -37.6%
33 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 926,016 $1.7m0.61% 0.61% AddedShares held: Q3 2025 157.7k, Q4 2025 167.5k, Q1 2026 180.1k, Q2 2026 926.0k +745.9k +745,933 414.2%
34 SPRUCE BIOSCIENCES INC COM NEW SPRB SPRB 30,000 $1.6m0.57% 0.57% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 10.0k, Q2 2026 30.0k +20.0k +20,000 200.0%
35 ARDELYX INC COM ARDX ARDX 303,025 $1.5m0.55% 0.55% NewShares held: Q3 2025 400.0k, Q4 2025 252.2k, Q1 2026 0, Q2 2026 303.0k
36 CUE BIOPHARMA INC COM CUE CUE 48,369 $1.5m0.54% 0.54% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 48.4k
37 MINERALYS THERAPEUTICS INC COM MLYS MLYS 56,347 $1.5m0.54% 0.54% AddedShares held: Q3 2025 0, Q4 2025 25.0k, Q1 2026 26.3k, Q2 2026 56.3k +30.0k +30,000 113.9%
38 PROTHENA CORP PLC SHS PRTA PRTA 149,482 $1.5m0.52% 0.52% NewShares held: Q3 2025 0, Q4 2025 106.5k, Q1 2026 0, Q2 2026 149.5k
39 VOYAGER THERAPEUTICS INC COM VYGR VYGR 413,642 $1.4m0.51% 0.51% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 423.6k, Q2 2026 413.6k -10.0k -10,000 -2.4%
40 UNICYCIVE THERAPEUTICS INC COM NEW UNCY UNCY 303,676 $1.4m0.50% 0.50% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 106.1k, Q2 2026 303.7k +197.6k +197,593 186.3%
41 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 129,950 $1.4m0.50% 0.50% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 54.6k, Q2 2026 129.9k +75.3k +75,300 137.8%
42 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 15,000 $1.3m0.47% 0.47% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 15.0k
43 CYBIN INC COM NEW COM NEW 200,000 $1.3m0.47% 0.47% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 200.0k
44 EQUILLIUM INC COM EQ EQ 400,282 $1.3m0.45% 0.45% ReducedShares held: Q3 2025 300.0k, Q4 2025 347.4k, Q1 2026 433.8k, Q2 2026 400.3k -33.6k -33,562 -7.7%
45 XERIS BIOPHARMA HOLDINGS INC COM XERS XERS 132,746 $1.1m0.37% 0.37% UnchangedShares held: Q3 2025 74.8k, Q4 2025 170.6k, Q1 2026 132.7k, Q2 2026 132.7k
46 PHARVARIS N V COM PHVS PHVS 29,321 $1.0m0.36% 0.36% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 29.3k, Q2 2026 29.3k
47 HARMONY BIOSCIENCES HLDGS IN COM HRMY HRMY 26,864 $978.1k0.35% 0.35% ReducedShares held: Q3 2025 50.0k, Q4 2025 7.5k, Q1 2026 92.9k, Q2 2026 26.9k -66.0k -66,000 -71.1%
48 CARTESIAN THERAPEUTICS INC COM NEW RNAC RNAC 87,057 $907.1k0.32% 0.32% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 87.1k
49 RIGEL PHARMACEUTICALS INC COM RIGL RIGL 22,816 $892.6k0.32% 0.32% NewShares held: Q3 2025 0, Q4 2025 30.0k, Q1 2026 0, Q2 2026 22.8k
50 SUMMIT THERAPEUTICS INC COM SMMT SMMT 60,000 $874.2k0.31% 0.31% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 60.0k
51 PRECIGEN INC COM PGEN PGEN 135,293 $771.2k0.27% 0.27% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 55.3k, Q2 2026 135.3k +80.0k +80,000 144.7%
52 DEFINIUM THERAPEUTICS INC COM SHS DFTX DFTX 15,451 $726.8k0.26% 0.26% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 15.5k
53 PELTHOS THERAPEUTICS INC COM SHS PTHS PTHS 24,773 $700.1k0.25% 0.25% UnchangedShares held: Q3 2025 10.5k, Q4 2025 25.0k, Q1 2026 24.8k, Q2 2026 24.8k
54 PEPGEN INC COM PEPG PEPG 373,284 $671.9k0.24% 0.24% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 150.9k, Q2 2026 373.3k +222.4k +222,359 147.3%
55 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 10,000 $507.5k0.18% 0.18% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 245, Q2 2026 10.0k +9.8k +9,755 3981.6%
56 CONNECT BIOPHARMA HLDGS LTD SHS CNTB CNTB 196,985 $468.8k0.17% 0.17% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 200.7k, Q2 2026 197.0k -3.7k -3,705 -1.9%
57 LARIMAR THERAPEUTICS INC COM LRMR LRMR 146,637 $447.2k0.16% 0.16% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 166.6k, Q2 2026 146.6k -20.0k -20,000 -12.0%
58 CELLECTAR BIOSCIENCES INC COM NEW CLRB CLRB 138,341 $384.6k0.14% 0.14% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 138.3k
59 FOGHORN THERAPEUTICS INC COM FHTX FHTX 66,908 $326.5k0.12% 0.12% ReducedShares held: Q3 2025 50.0k, Q4 2025 30.6k, Q1 2026 79.9k, Q2 2026 66.9k -13.0k -13,036 -16.3%
60 AYTU BIOPHARMA INC COM AYTU AYTU 148,546 $319.4k0.11% 0.11% ReducedShares held: Q3 2025 272.7k, Q4 2025 305.8k, Q1 2026 353.1k, Q2 2026 148.5k -204.5k -204,531 -57.9%
61 OCUGEN INC COM OCGN OCGN 200,000 $306.0k0.11% 0.11% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 200.0k, Q2 2026 200.0k
62 UROGEN PHARMA LTD COM URGN URGN 7,137 $262.6k0.09% 0.09% ReducedShares held: Q3 2025 90.0k, Q4 2025 21.8k, Q1 2026 23.2k, Q2 2026 7.1k -16.0k -16,018 -69.2%
63 AMGEN INC COM AMGN AMGN 102,701 $214.6k0.08% 0.08% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 102.7k
64 HERON THERAPEUTICS INC COM HRTX HRTX 458,723 $195.8k0.07% 0.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 458.7k
65 TALPHERA INC COM NEW TLPH TLPH 153,563 $158.2k0.06% 0.06% UnchangedShares held: Q3 2025 0, Q4 2025 136.9k, Q1 2026 153.6k, Q2 2026 153.6k
66 ANNEXON INC COM ANNX ANNX 27,516 $157.1k0.06% 0.06% ReducedShares held: Q3 2025 0, Q4 2025 350.0k, Q1 2026 132.9k, Q2 2026 27.5k -105.4k -105,400 -79.3%
67 MONOPAR THERAPEUTICS INC COM NEW MNPR MNPR 1,630 $150.9k0.05% 0.05% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.6k, Q2 2026 1.6k
68 LAKELAND INDS INC COM LAKE LAKE 14,108 $150.8k0.05% 0.05% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 14.1k
69 UPSTREAM BIO INC COM UPB UPB 19,093 $132.1k0.05% 0.05% ReducedShares held: Q3 2025 0, Q4 2025 20.5k, Q1 2026 21.6k, Q2 2026 19.1k -2.5k -2,516 -11.6%
70 MEIRAGTX HLDGS PLC COM MGTX MGTX 8,368 $113.1k0.04% 0.04% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 8.4k
71 JATT II ACQUISITION CORP ORD SHS JATT JATT 9,021 $102.5k0.04% 0.04% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 9.0k
72 KAILERA THERAPEUTICS INC COMMON STOCK KLRA KLRA 3,621 $79.8k0.03% 0.03% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.6k
73 MANNKIND CORP COM NEW MNKD MNKD 16,003 $68.2k0.02% 0.02% ReducedShares held: Q3 2025 212.5k, Q4 2025 302.0k, Q1 2026 186.6k, Q2 2026 16.0k -170.6k -170,600 -91.4%
74 ENTERA BIO LTD SHS ENTX ENTX 23,260 $41.2k0.01% 0.01% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 23.3k, Q2 2026 23.3k
75 ARS PHARMACEUTICALS INC COM SPRY SPRY 4,860 $38.9k0.01% 0.01% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 4.9k
76 APREA THERAPEUTICS INC COM NEW APRE APRE 44,907 $36.0k0.01% 0.01% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 44.9k
77 TVARDI THERAPEUTICS INC COM TVRD TVRD 16,607 $31.6k0.01% 0.01% NewShares held: Q3 2025 2.2k, Q4 2025 0, Q1 2026 0, Q2 2026 16.6k
78 NEXTCURE INC COM NEW NXTC NXTC 7,742 $12.4k0.00% 0.00% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 7.7k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
BRIDGEBIO PHARMA INC BBIO 1.75 03.01.31 BBIO 1.75 03.01.31 250,000 $18.6m250.0k shares
JAZZ PHARMACEUTICALS PLC JAZZ JAZZ 54,755 $10.4m54.8k shares
TERNS PHARMACEUTICALS INC 181,752 $9.6m181.8k shares
INCYTE CORP INCY INCY 78,029 $7.3m78.0k shares
TG THERAPEUTICS INC TGTX TGTX 206,928 $6.9m206.9k shares
BRIDGEBIO PHARMA INC BBIO BBIO 85,311 $6.3m85.3k shares
ELI LILLY & CO LLY LLY 6,000 $5.5m6.0k shares
ABBVIE INC ABBV ABBV 24,058 $5.2m24.1k shares
STRUCTURE THERAPEUTICS INC GPCR GPCR 72,234 $3.5m72.2k shares
TENAX THERAPEUTICS INC TENX TENX 179,738 $2.9m179.7k shares
CAPRICOR THERAPEUTICS INC CAPR CAPR 78,851 $2.4m78.9k shares
EYEPOINT PHARMACEUTICALS INC EYPT EYPT 178,545 $2.3m178.5k shares
CLIMB BIO INC CLYM CLYM 286,126 $2.0m286.1k shares
SHATTUCK LABS INC STTK STTK 293,664 $1.9m293.7k shares
TARSUS PHARMACEUTICALS INC TARS TARS 25,942 $1.8m25.9k shares
ALKERMES PLC ALKS ALKS 50,000 $1.8m50.0k shares
VERTEX PHARMACEUTICALS INC VRTX VRTX 3,840 $1.7m3.8k shares
INOVIO PHARMACEUTICALS INC INO INO 562,665 $979.0k562.7k shares
DIANTHUS THERAPEUTICS INC DNTH DNTH 10,000 $839.2k10.0k shares
ENANTA PHARMACEUTICALS INC ENTA ENTA 64,952 $820.3k65.0k shares
REPLIMUNE GROUP INC REPL REPL 100,660 $770.0k100.7k shares
ULTRAGENYX PHARMACEUTICAL IN RARE RARE 35,144 $736.3k35.1k shares
CELCUITY INC CELC CELC 5,314 $606.5k5.3k shares
UNIQURE NV QURE QURE 31,200 $510.1k31.2k shares
MAZE THERAPEUTICS INC MAZE MAZE 15,000 $447.8k15.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
VIKING THERAPEUTICS INC VKTX · Call VKTXCall 1,220,800 $47.6m1.2m shares Added
ABIVAX SA ABVX · Call ABVXCall 349,200 $46.5m349.2k shares Added
BRISTOL-MYERS SQUIBB CO BMY · Call BMYCall 600,000 $34.6m600.0k shares New
ABIVAX SA ABVX · Put ABVXPut 252,400 $33.6m252.4k shares Added
BRISTOL-MYERS SQUIBB CO BMY · Put BMYPut 330,600 $19.0m330.6k shares New
CORCEPT THERAPEUTICS INC CORT · Call CORTCall 206,300 $17.9m206.3k shares Added
KYMERA THERAPEUTICS INC KYMR · Call KYMRCall 149,700 $17.2m149.7k shares New
NOVARTIS AG NVS · Put NVSPut 100,000 $15.7m100.0k shares New
UNIQURE NV QURE · Put QUREPut 299,000 $13.8m299.0k shares Unchanged
VIKING THERAPEUTICS INC VKTX · Put VKTXPut 350,500 $13.7m350.5k shares New
BIOGEN INC BIIB · Call BIIBCall 60,000 $13.0m60.0k shares New
CAPRICOR THERAPEUTICS INC CAPR · Put CAPRPut 534,400 $12.9m534.4k shares Reduced
SUMMIT THERAPEUTICS INC SMMT · Call SMMTCall 860,200 $12.5m860.2k shares New
ELI LILLY & CO LLY · Put LLYPut 10,000 $12.0m10.0k shares New
INCYTE CORP INCY · Put INCYPut 105,400 $11.9m105.4k shares Unchanged
UNIQURE NV QURE · Call QURECall 235,400 $10.8m235.4k shares Reduced
BIONTECH SE BNTX · Call BNTXCall 100,000 $9.3m100.0k shares New
CAPRICOR THERAPEUTICS INC CAPR · Call CAPRCall 329,300 $7.9m329.3k shares Unchanged
NOVARTIS AG NVS · Call NVSCall 50,000 $7.8m50.0k shares New
REPLIMUNE GROUP INC REPL · Call REPLCall 696,300 $7.7m696.3k shares Added
KODIAK SCIENCES INC KOD · Call KODCall 196,700 $7.7m196.7k shares Added
MODERNA INC MRNA · Put MRNAPut 100,000 $7.0m100.0k shares Reduced
HIMS & HERS HEALTH INC HIMS · Call HIMSCall 200,000 $6.9m200.0k shares New
HIMS & HERS HEALTH INC HIMS · Put HIMSPut 193,700 $6.7m193.7k shares New
CORBUS PHARMACEUTICALS HLDGS CRBP · Call CRBPCall 633,800 $5.9m633.8k shares Added